DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Asthma - Pipeline Review, H1 2016" report to their offering.
This report provides comprehensive information on the therapeutic development for Asthma, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Asthma and special features on late-stage and discontinued projects.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.
Key Topics Covered:
- Introduction
- Asthma Overview
- Therapeutics Development
- Pipeline Products for Asthma - Overview
- Pipeline Products for Asthma - Comparative Analysis
- Asthma - Therapeutics under Development by Companies
- Asthma - Therapeutics under Investigation by Universities/Institutes
- Asthma Products Glance
- Late Stage Products
- Clinical Stage Products
- Early Stage Products
- Asthma - Products under Development by Companies
- Asthma - Products under Investigation by Universities/Institutes
- Asthma - Companies Involved in Therapeutics Development
- 4D Pharma Plc
- AB Science SA
- Abeome Corporation
- Accolade Pharmaceuticals, LLC
- Acorda Therapeutics, Inc.
- Adamis Pharmaceuticals Corporation
- Advinus Therapeutics Ltd.
- Afferent Pharmaceuticals, Inc.
- ALK-Abello A/S
- Allergopharma GmbH & Co. KG
- Almirall, S.A.
- Amakem NV
- Amgen Inc.
- AnaptysBio, Inc.
- Antisense Therapeutics Limited
- Aquinox Pharmaceuticals Inc.
- ARA Healthcare Pvt. Ltd.
- Ario Pharma Ltd
- ASIT biotech s.a.
- Aslan Pharmaceuticals Pte. Ltd.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Asubio Pharma Co., Ltd.
- Aurigene Discovery Technologies Limited
- Axikin Pharmaceuticals, Inc.
- Baxalta Incorporated
- Bioncotech Therapeutics S.L.
- Biotec Pharmacon ASA
- Boehringer Ingelheim GmbH
- Caladrius Biosciences, Inc.
- CalciMedica, Inc.
- Carolus Therapeutics, Inc.
- Cellceutix Corporation
- Cellular Biomedicine Group, Inc.
- Celon Pharma Sp. z o.o.
For more information visit http://www.researchandmarkets.com/research/q4qvxl/asthma_pipeline